Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 7/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2873710 | 0.89 | SLC6A4 (0.51) | SLC6A4 | |
| SCHEMBL9721858 | 0.86 | SLC6A4 (0.53) | SLC6A4 | |
| SCHEMBL9721823 | 0.86 | SLC6A4 (0.53) | SLC6A4 | |
| SCHEMBL2006721 | 0.83 | SLC6A4 (0.75) | SLC6A4 | |
| SCHEMBL339642 | 0.83 | SLC6A4 (0.75) | SLC6A4 | |
| SCHEMBL7561729 | 0.83 | SLC6A4 (0.53) | SLC6A4 | |
| SCHEMBL2009409 | 0.83 | SLC6A4 (0.75) | SLC6A4 | |
| SCHEMBL6654388 | 0.83 | SLC6A4 (0.58) | SLC6A4 | |
| SCHEMBL7688733 | 0.82 | SLC6A4 (0.73) | SLC6A4 | |
| SCHEMBL30681653 | 0.81 | SLC6A4 (0.69) | SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1706394-B1 | PREPARATION OF ESCITALOPRAM | REDDYS LAB INC DR (US) | 2014-12-17 | — | — | EP | disclosed |
| US-20090018351-A1 | PREPARATION OF ESCITALOPRAM | DR. REDDY'S LABORATORIES, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| EP-1706394-A4 | PREPARATION OF ESCITALOPRAM | REDDYS LAB INC DR (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1706394-A1 | PREPARATION OF ESCITALOPRAM | Dr. Reddy's Laboratories, Inc. (US) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005047274-A1 | PREPARATION OF ESCITALOPRAM | DR. REDDY'S LABORATORIES, INC. (US) | 2005-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018351-A1 | PREPARATION OF ESCITALOPRAM | HTR4, SLC6A4, HTR5A | SLC6A4 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.